AssetMark Inc’s BioLife Solutions BLFS Stock Holding History

AssetMark Inc’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$791	Hold	28	–	–	﹤0.01%	3192
2026 Q1	$534	Hold	28	–	–	﹤0.01%	3174
2025 Q4	$677	Buy	+28	New	+$733	﹤0.01%	3038

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AssetMark Inc's BLFS Position: Q2 2026 in Review

AssetMark Inc held its BioLife Solutions (BLFS) position steady in Q2 2026 at 28 shares worth $791. The position accounts for ﹤0.01% of the portfolio, ranked #3192.

AssetMark Inc first reported a position in BLFS in Q4 2025 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

AssetMark Inc held 28 shares of BioLife Solutions worth $791 as of Q2 2026.
AssetMark Inc left its BioLife Solutions share count unchanged in Q2 2026.
BioLife Solutions made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3192 holding.
AssetMark Inc first reported a position in BioLife Solutions in Q4 2025 and has held it in 3 quarters since.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.